{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T01:47:10Z","timestamp":1783648030274,"version":"3.55.0"},"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T00:00:00Z","timestamp":1682553600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA230328"],"award-info":[{"award-number":["R01CA230328"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K01CA229995"],"award-info":[{"award-number":["K01CA229995"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Introduction<\/jats:title>\n<jats:p>Many patients with growth hormone-secreting pituitary adenoma (GHPA) fail to achieve biochemical remission, warranting investigation into epigenetic and molecular signatures associated with tumorigenesis and hormonal secretion. Prior work exploring the DNA methylome showed <jats:italic>Myc<\/jats:italic>-Associated Protein X (MAX), a transcription factor involved in cell cycle regulation, was differentially methylated between GHPA and nonfunctional pituitary adenoma (NFPA). We aimed to validate the differential DNA methylation and related MAX protein expression profiles between NFPA and GHPA.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>DNA methylation levels were measured in 52 surgically resected tumors (37 NFPA, 15 GHPA) at ~100,000 known MAX binding sites derived using ChIP-seq analysis from ENCODE. Findings were correlated with MAX protein expression using a constructed tissue microarray (TMA). Gene ontology analysis was performed to explore downstream genetic and signaling pathways regulated by MAX.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>GHPA had more hypomethylation events across all known MAX binding sites. Of binding sites defined using ChIP-seq analysis, 1,551 sites had significantly different methylation patterns between the two cohorts; 432 occurred near promoter regions potentially regulated by MAX, including promoters of TNF and MMP9. Gene ontology analysis suggested enrichment in genes involved in oxygen response, immune system regulation, and cell proliferation. Thirteen MAX binding sites were within coding regions of genes. GHPA demonstrated significantly increased expression of MAX protein compared to NFPA.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>GHPA have significantly different DNA methylation and downstream protein expression levels of MAX compared to NFPA. These differences may influence mechanisms involved with cellular proliferation, tumor invasion and hormonal secretion.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0284949","type":"journal-article","created":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T17:41:47Z","timestamp":1682617307000},"page":"e0284949","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":5,"title":["Validation of Myc-Associated Protein X (MAX) regulation in growth hormone secreting and nonfunctional pituitary adenoma"],"prefix":"10.1371","volume":"18","author":[{"given":"Douglass W.","family":"Tucker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7391-9825","authenticated-orcid":true,"given":"Dhiraj J.","family":"Pangal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angad S.","family":"Gogia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Tafreshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Ruzevick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle T.","family":"Hurth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Triche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9105-3519","authenticated-orcid":true,"given":"Alexander","family":"Micko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Carpten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark S.","family":"Shiroishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Carmichael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suhn K.","family":"Rhie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Zada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2023,4,27]]},"reference":[{"key":"pone.0284949.ref001","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1056\/NEJMra062453","article-title":"Medical progress: Acromegaly","volume":"355","author":"S. Melmed","year":"2006","journal-title":"N Engl J Med"},{"key":"pone.0284949.ref002","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/s41574-018-0058-5","article-title":"A Consensus Statement on acromegaly therapeutic outcomes.","volume":"14","author":"S Melmed","year":"2018","journal-title":"Nat Rev Endocrinol."},{"key":"pone.0284949.ref003","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1210\/jc.2004-2231","article-title":"Clinical review: Diagnosis and management of pituitary carcinomas","volume":"90","author":"GA Kaltsas","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"pone.0284949.ref004","doi-asserted-by":"crossref","first-page":"e1360","DOI":"10.1016\/j.wneu.2020.12.013","article-title":"Prognostic Factors of Acromegalic Patients with Growth Hormone-Secreting Pituitary Adenoma After Transsphenoidal Surgery","volume":"146","author":"C Taweesomboonyat","year":"2021","journal-title":"World Neurosurg"},{"key":"pone.0284949.ref005","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s11102-016-0781-7","article-title":"Management of aggressive growth hormone secreting pituitary adenomas.","volume":"20","author":"DA Donoho","year":"2017","journal-title":"Pituitary."},{"key":"pone.0284949.ref006","first-page":"1","article-title":"Long-term outcomes after endoscopic endonasal surgery for nonfunctioning pituitary macroadenomas","author":"MM Gerges","year":"2020","journal-title":"J Neurosurg"},{"key":"pone.0284949.ref007","doi-asserted-by":"crossref","first-page":"736","DOI":"10.3171\/JNS\/2008\/108\/4\/0736","article-title":"Long-term recurrence and mortality after surgery and adjuvant radiotherapy for nonfunctional pituitary adenomas","volume":"108","author":"EF Chang","year":"2008","journal-title":"J Neurosurg"},{"key":"pone.0284949.ref008","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.3390\/jcm10071377","article-title":"Genetics of Acromegaly and Gigantism","volume":"10","author":"A Bogus\u0142awska","year":"2021","journal-title":"J Clin Med"},{"key":"pone.0284949.ref009","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1530\/EJE-15-1064","article-title":"Landscape of somatic mutations in sporadic GH-secreting pituitary adenomas","volume":"174","author":"CL Ronchi","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"pone.0284949.ref010","doi-asserted-by":"crossref","first-page":"e96178","DOI":"10.1371\/journal.pone.0096178","article-title":"A pilot genome-scale profiling of DNA methylation in sporadic pituitary macroadenomas: association with tumor invasion and histopathological subtype","volume":"9","author":"C Ling","year":"2014","journal-title":"PLoS One"},{"key":"pone.0284949.ref011","doi-asserted-by":"crossref","first-page":"4126","DOI":"10.1158\/1078-0432.CCR-17-2206","article-title":"The Epigenomic Landscape of Pituitary Adenomas Reveals Specific Alterations and Differentiates Among Acromegaly, Cushing\u2019s Disease and Endocrine-Inactive Subtypes","volume":"24","author":"MP Salomon","year":"2018","journal-title":"Clin Cancer Res"},{"key":"pone.0284949.ref012","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3171\/2019.12.JNS192435","article-title":"Role of KCNAB2 expression in modulating hormone secretion in somatotroph pituitary adenoma","author":"C Ashton","year":"2020","journal-title":"J Neurosurg"},{"key":"pone.0284949.ref013","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s10014-017-0307-7","article-title":"New WHO classification of pituitary adenomas (4th edition): assessment of pituitary transcription factors and the prognostic histological factors.","volume":"35","author":"H Nishioka","year":"2018","journal-title":"Brain Tumor Pathol"},{"key":"pone.0284949.ref014","doi-asserted-by":"crossref","first-page":"L37","DOI":"10.1530\/ERC-18-0065","article-title":"Pheochromocytomas and pituitary adenomas in three patients with MAX exon deletions","volume":"25","author":"AF Daly","year":"2018","journal-title":"Endocr Relat Cancer"},{"key":"pone.0284949.ref015","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1158\/1078-0432.CCR-12-0160","article-title":"MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma","volume":"18","author":"N Burnichon","year":"2012","journal-title":"Clin Cancer Res"},{"key":"pone.0284949.ref016","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.cmet.2013.04.013","article-title":"EGFR mutation-induced alternative splicing of Max contributes to growth of glycolytic tumors in brain cancer","volume":"17","author":"I Babic","year":"2013","journal-title":"Cell Metab"},{"key":"pone.0284949.ref017","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1210\/js.2017-00135","article-title":"Case Report of a Prolactinoma in a Patient With a Novel MAX Mutation and Bilateral Pheochromocytomas.","volume":"1","author":"KL Roszko","year":"2017","journal-title":"J Endocr Soc."},{"key":"pone.0284949.ref018","doi-asserted-by":"crossref","first-page":"D794","DOI":"10.1093\/nar\/gkx1081","article-title":"The Encyclopedia of DNA elements (ENCODE): data portal update.","volume":"46","author":"CA Davis","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"pone.0284949.ref019","doi-asserted-by":"crossref","first-page":"e54114","DOI":"10.1371\/journal.pone.0054114","article-title":"DNA methylation in the malignant transformation of meningiomas","volume":"8","author":"F Gao","year":"2013","journal-title":"PLoS One"},{"key":"pone.0284949.ref020","doi-asserted-by":"crossref","first-page":"D766","DOI":"10.1093\/nar\/gky955","article-title":"GENCODE reference annotation for the human and mouse genomes","volume":"47","author":"A Frankish","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"pone.0284949.ref021","unstructured":"Tucker DW, Pangal DJ, Hurth K, Jr TT, Carpten JD, Carmichael JD, et al. Myc-Associated Protein X (MAX) Regulation in Growth Hormone Secreting and Nonfunctional Pituitary Adenoma. (Pending Deposit in Repository)."},{"key":"pone.0284949.ref022","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/1471-2105-14-244","article-title":"RCircos: an R package for Circos 2D track plots","volume":"14","author":"H Zhang","year":"2013","journal-title":"BMC Bioinformatics"},{"key":"pone.0284949.ref023","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1158\/1078-0432.CCR-17-1958","article-title":"Epigenetic Reprogramming Strategies to Reverse Global Loss of 5-Hydroxymethylcytosine, a Prognostic Factor for Poor Survival in High-grade Serous Ovarian Cancer","volume":"24","author":"DW Tucker","year":"2018","journal-title":"Clin Cancer Res"},{"key":"pone.0284949.ref024","doi-asserted-by":"crossref","first-page":"514","DOI":"10.3390\/cancers12020514","article-title":"How to Classify Pituitary Neuroendocrine Tumors (PitNET)s in 2020.","volume":"12","author":"J Trouillas","year":"2020","journal-title":"Cancers (Basel)."},{"key":"pone.0284949.ref025","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s11102-017-0803-0","article-title":"Expression of cell cycle regulators and biomarkers of proliferation and regrowth in human pituitary adenomas","volume":"20","author":"M Gruppetta","year":"2017","journal-title":"Pituitary"},{"key":"pone.0284949.ref026","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.3892\/mmr.2017.6169","article-title":"Increased \u03b2\u2011catenin and c-myc expression predict aggressive growth of non-functioning pituitary adenomas: An assessment using a tissue microarray-based approach","volume":"15","author":"C Liu","year":"2017","journal-title":"Mol Med Rep"},{"key":"pone.0284949.ref027","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3390\/diagnostics10040227","article-title":"Increased E2F1 mRNA and miR-17-5p Expression Is Correlated to Invasiveness and Proliferation of Pituitary Neuroendocrine Tumours.","volume":"10","author":"A Garc\u00eda-Mart\u00ednez","year":"2020","journal-title":"Diagnostics (Basel)."},{"key":"pone.0284949.ref028","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1210\/endo-127-1-101","article-title":"Tumor necrosis factor alpha inhibits the hormonal response of the pituitary gland to hypothalamic releasing factors","volume":"127","author":"RC Gaillard","year":"1990","journal-title":"Endocrinology"},{"key":"pone.0284949.ref029","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.mce.2016.07.025","article-title":"Integrative proteomics and transcriptomics revealed that activation of the IL-6R\/JAK2\/STAT3\/MMP9 signaling pathway is correlated with invasion of pituitary null cell adenomas","volume":"436","author":"J Feng","year":"2016","journal-title":"Mol Cell Endocrinol"},{"key":"pone.0284949.ref030","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1210\/me.2008-0107","article-title":"Thyroid hormone-mediated activation of the ERK\/dual specificity phosphatase 1 pathway augments the apoptosis of GH4C1 cells by down-regulating nuclear factor-kappaB activity","volume":"22","author":"A Chiloeches","year":"2008","journal-title":"Mol Endocrinol"},{"key":"pone.0284949.ref031","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.mce.2018.01.020","article-title":"DNA methylation profiling in nonfunctioning pituitary adenomas","volume":"473","author":"P Kober","year":"2018","journal-title":"Mol Cell Endocrinol"},{"key":"pone.0284949.ref032","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s11102-016-0737-y","article-title":"The role of combination medical therapy in the treatment of acromegaly.","volume":"20","author":"DST Lim","year":"2017","journal-title":"Pituitary."},{"key":"pone.0284949.ref033","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1210\/er.2010-0002","article-title":"Resistance to somatostatin analogs in acromegaly","volume":"32","author":"A Colao","year":"2011","journal-title":"Endocr Rev"},{"key":"pone.0284949.ref034","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12902-016-0096-8","article-title":"Switching patients with acromegaly from octreotide to pasireotide improves biochemical control: crossover extension to a randomized, double-blind, Phase III study.","volume":"16","author":"MD Bronstein","year":"2016","journal-title":"BMC Endocr Disord"},{"key":"pone.0284949.ref035","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s11102-015-0684-z","article-title":"Interpreting biochemical control response rates with first-generation somatostatin analogues in acromegaly.","volume":"19","author":"A Colao","year":"2016","journal-title":"Pituitary."},{"key":"pone.0284949.ref036","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s11102-016-0782-6","article-title":"Cabergoline in acromegaly.","volume":"20","author":"E Kuhn","year":"2017","journal-title":"Pituitary."},{"key":"pone.0284949.ref037","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2147\/TCRM.S183360","article-title":"Octreotide-Resistant Acromegaly: Challenges and Solutions","volume":"16","author":"G Corica","year":"2020","journal-title":"Ther Clin Risk Manag"},{"key":"pone.0284949.ref038","article-title":"More than a decade of real-world experience of pegvisomant for acromegaly: ACROSTUDY","author":"M Fleseriu","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"pone.0284949.ref039","doi-asserted-by":"crossref","first-page":"10064","DOI":"10.1038\/s41598-018-28107-4","article-title":"A selective high affinity MYC-binding compound inhibits MYC:MAX interaction and MYC-dependent tumor cell proliferation","volume":"8","author":"A Castell","year":"2018","journal-title":"Sci Rep"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0284949","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T17:42:25Z","timestamp":1682617345000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0284949"}},"subtitle":[],"editor":[{"given":"Dorra","family":"H\u2019mida Ben Brahim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,4,27]]},"references-count":39,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,4,27]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0284949","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,27]]}}}